Accès à distance ? S'identifier sur le proxy UCLouvain
A single dose of zoledronic acid 5 mg achieves more sustained biochemical remission versus daily 30 mg risedronate in patients with Paget's disease.
Primary tabs
| Document type | Communication à un colloque (Conference Paper) – Abstract, Présentation orale avec comité de sélection |
|---|---|
| Publication date | 2006 |
| Language | Anglais |
| Conference | "28th Annual Meeting of the American-Society-for-Bone-and-Mineral-Research", Philadelphia (Pa) (Sep 15-19, 2006) |
| Journal information | "Journal of Bone and Mineral Research" - Vol. 21, p. S437-S437 (2006) |
| Peer reviewed | yes |
| issn | 0884-0431 |
| e-issn | 1523-4681 |
| Publisher | Amer Soc Bone & Mineral Res (Washington) |
| Affiliations |
UCL
- Cliniques universitaires Saint-Luc UCL |
| Links |
| Bibliographic reference | Reid, I. R. ; Devogelaer, Jean-Pierre ; Miller, P. ; Brown, J. ; Fraser, W. ; et. al. A single dose of zoledronic acid 5 mg achieves more sustained biochemical remission versus daily 30 mg risedronate in patients with Paget's disease..28th Annual Meeting of the American-Society-for-Bone-and-Mineral-Research (Philadelphia (Pa), Sep 15-19, 2006). In: Journal of Bone and Mineral Research, Vol. 21, p. S437-S437 (2006) |
|---|---|
| Permanent URL | http://hdl.handle.net/2078.1/59729 |